Endologix has acquired Surmodics' Pounce System, a platform for non-surgical peripheral arterial thrombi removal, expanding ...

Endologix will market the system to vascular interventionists who use its other devices to treat peripheral artery disease ...

Endologix announced the acquisition of the Pounce thrombectomy system from Surmodics, expanding the company’s portfolio of pe ...

The acquisition expands Endologix’s device options for clinical partners already utilising its Detour, Alto, and AFX2 ...

Endologix LLC, a privately held, global medical device company focused on advancing innovative therapies for the ...

Surmodics looks to pave a new path forward after the FDA sent a device submission back for revision yet again. The device in question is its SurVeil drug-coated balloon, which is threaded into a blood ...

Surmodics is a medical device maker that makes coatings for medical devices and manufactures chemicals for diagnostic immunoassay tests The company will make a drug-coated balloon that will be sold by ...

Shares of SurModics (SRDX) have been on an upswing since reporting a solid fiscal third quarter in early August, and recently hit its 52-week high of $22.21 on October 5. With a year-to-date return of ...

It has been about a month since the last earnings report for SurModics (SRDX). Shares have lost about 37.2% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...

Surmodics, Inc. SRDX is a leading provider of medical device and in vitro diagnostic technologies to the health care industry that could be an interesting play for investors. That is because, not only ...

Irvine medical device maker Endologix today announced its acquisition of the Pounce Thrombectomy System from Minnesota-based ...